TY - JOUR
KW - Administration, Cutaneous
KW - Analgesics, Opioid/administration & dosage
KW - Buprenorphine, Naloxone Drug Combination/administration & dosage
KW - Delayed-Action Preparations/administration & dosage
KW - Fentanyl/administration & dosage
KW - Humans
KW - Inpatients
KW - Male
KW - Methadone/administration & dosage
KW - Middle Aged
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy/psychology
KW - Substance Withdrawal Syndrome/prevention & control/psychology
KW - Treatment Outcome
AU - P. Azar
AU - M. Nikoo
AU - I. Miles
A1 - 
BT - The American journal on addictions
C5 - Opioids & Substance Use
CP - 8
CY - England
DO - 10.1111/ajad.12809
IS - 8
JF - The American journal on addictions
PB - American Academy of Addiction Psychiatry
PP - England
PY - 2018
SN - 1521-0391; 1055-0496
SP - 601
EP - 604
EP - 
T1 - Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method
T2 - The American journal on addictions
TI - Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method
U1 - Opioids & Substance Use
U2 - 30387894
U3 - 10.1111/ajad.12809
VL - 27
VO - 1521-0391; 1055-0496
Y1 - 2018
ER -